Michael A. Yarski

662 total citations
7 papers, 504 citations indexed

About

Michael A. Yarski is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Michael A. Yarski has authored 7 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cardiology and Cardiovascular Medicine, 3 papers in Molecular Biology and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Michael A. Yarski's work include Renin-Angiotensin System Studies (4 papers), Hormonal Regulation and Hypertension (3 papers) and Receptor Mechanisms and Signaling (2 papers). Michael A. Yarski is often cited by papers focused on Renin-Angiotensin System Studies (4 papers), Hormonal Regulation and Hypertension (3 papers) and Receptor Mechanisms and Signaling (2 papers). Michael A. Yarski collaborates with scholars based in Australia, United States and Singapore. Michael A. Yarski's co-authors include Rebecca A. Lew, A. Ian Smith, Moira K. O’Bryan, Mark P. Hedger, Louise M. Burrell, Fiona J. Warner, Iresha Hanchapola, C. I. Johnston, Wendy C. Burns and Josephine M. Forbes and has published in prestigious journals such as Nature Genetics, Immunity and Endocrinology.

In The Last Decade

Michael A. Yarski

7 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael A. Yarski Australia 6 158 142 109 100 85 7 504
Eva Königshausen Germany 10 126 0.8× 84 0.6× 25 0.2× 71 0.7× 136 1.6× 20 466
Mengzhen Dong China 9 26 0.2× 169 1.2× 19 0.2× 76 0.8× 101 1.2× 21 542
Vanesa Palau Spain 7 50 0.3× 216 1.5× 16 0.1× 75 0.8× 54 0.6× 11 367
Zuzanna Drebert Belgium 9 42 0.3× 26 0.2× 7 0.1× 69 0.7× 94 1.1× 17 427
José Rafael Villafán-Bernal Mexico 13 12 0.1× 24 0.2× 100 0.9× 49 0.5× 80 0.9× 46 417
Moriatsu Miyagi Japan 9 166 1.1× 72 0.5× 17 0.2× 125 1.3× 41 0.5× 12 382
Ahmed Amer Germany 11 73 0.5× 26 0.2× 7 0.1× 106 1.1× 73 0.9× 25 443
Stephanie T. Page United States 12 33 0.2× 67 0.5× 31 0.3× 133 1.3× 108 1.3× 22 573
Rebeca Lorca Spain 12 326 2.1× 127 0.9× 24 0.2× 9 0.1× 101 1.2× 56 551
Giuseppe Ruocco Italy 12 38 0.2× 68 0.5× 6 0.1× 179 1.8× 38 0.4× 18 446

Countries citing papers authored by Michael A. Yarski

Since Specialization
Citations

This map shows the geographic impact of Michael A. Yarski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Yarski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Yarski more than expected).

Fields of papers citing papers by Michael A. Yarski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Yarski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Yarski. The network helps show where Michael A. Yarski may publish in the future.

Co-authorship network of co-authors of Michael A. Yarski

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Yarski. A scholar is included among the top collaborators of Michael A. Yarski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Yarski. Michael A. Yarski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Karunarathne, Deshapriya S., Joshua M. Horne‐Debets, Johnny X. Huang, et al.. (2016). Programmed Death-1 Ligand 2-Mediated Regulation of the PD-L1 to PD-1 Axis Is Essential for Establishing CD4 + T Cell Immunity. Immunity. 45(2). 333–345. 84 indexed citations
2.
Lai, Zon Weng, Rebecca A. Lew, Michael A. Yarski, et al.. (2009). The Identification of a Calmodulin-Binding Domain within the Cytoplasmic Tail of Angiotensin-Converting Enzyme-2. Endocrinology. 150(5). 2376–2381. 27 indexed citations
3.
Lew, Rebecca A., Fiona J. Warner, Iresha Hanchapola, et al.. (2008). Angiotensin‐converting enzyme 2 catalytic activity in human plasma is masked by an endogenous inhibitor. Experimental Physiology. 93(5). 685–693. 102 indexed citations
4.
Harikrishnan, K N, Sharmistha Pal, Michael A. Yarski, et al.. (2006). Reply to “Testing for association between MeCP2 and the brahma-associated SWI/SNF chromatin-remodeling complex”. Nature Genetics. 38(9). 964–967. 11 indexed citations
5.
Tikellis, Chris, C. I. Johnston, Josephine M. Forbes, et al.. (2004). Identification of angiotensin converting enzyme 2 in the rodent retina. Current Eye Research. 29(6). 419–427. 66 indexed citations
6.
O’Bryan, Moira K., et al.. (2004). The Novel Angiotensin-Converting Enzyme (ACE) Homolog, ACE2, Is Selectively Expressed by Adult Leydig Cells of the Testis. Endocrinology. 145(10). 4703–4711. 212 indexed citations
7.
Bradshaw, Ralph, et al.. (1994). Polypeptide growth factors: Structure, function and mechanism of action. Pure and Applied Chemistry. 66(1). 9–14. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026